NCT07445412

Brief Summary

The goal of this national mutlticenter observational study is to learn and describe trends over time in the use of techniques for inducing hepatic hypertrophy in Italy. Patients will be treated according to the current clinical practice of the participating centers and will be observed from the moment of recruitment and throughout their stay. Information on vital status will be collected, as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner. There are also plans to retrospectively collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
166mo left

Started Oct 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Oct 2024Apr 2040

Study Start

First participant enrolled

October 22, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 17, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
13.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2039

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2040

Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

15 years

First QC Date

February 17, 2026

Last Update Submit

February 25, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Describe the temporal trends in the use of techniques for inducing hepatic hypertrophy in Italy

    through study completion, an average of 1 year

  • compare the techniques used in terms of function and volumetric hypertrophy

    through study completion, an average of 1 year

  • compare the techniques used in terms of drop-out

    through study completion, an average of 1 year

  • compare the techniques used in terms of 90-day mortality

    through study completion, an average of 1 year

  • compare the techniques used in terms of long-term survival

    through study completion, an average of 1 year

  • compare the techniques used in terms of disease-free survival

    through study completion, an average of 1 year

Study Arms (2)

Prospective cohort

The clinical information from prospectice cohort will be collected from the moment of recruitment , as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner.

Retrospective Cohort

There is also a plan to collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes patients with potentially resectable primary or secondary liver tumors. An anatomical-pathological situation is defined as potentially resectable if a small residual liver requires regenerative procedures prior to liver resection to avoid the risk of post-resection liver failure

You may qualify if:

  • Patients aged 18 or older
  • Obtaining informed consent
  • Patients with liver neoplasia (benign or malignant) and with a future liver remnant volume deemed insufficient (\<20%-40%) by the local multidisciplinary team

You may not qualify if:

  • pregnant or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitario di Bologna

Bologna, Bologna, 401328, Italy

RECRUITING

MeSH Terms

Conditions

Carcinoma, HepatocellularLiver NeoplasmsNeoplasm Metastasis

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Elio Jovine, MD

    IRCCS Policlinico di Sant'Orsola - Malpighi (Bologna, Italy)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2026

First Posted

March 3, 2026

Study Start

October 22, 2024

Primary Completion (Estimated)

October 1, 2039

Study Completion (Estimated)

April 1, 2040

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP

Locations